In a melanoma mouse model, DNA vaccination was administered together with intratumoral delivery of antiangiogenic plasmids, encoding angiostatin, and endostatin. Combined melanoma vaccination resulted in 57% tumorfree survival over 90 days after challenge [54] . In a modest proportion of patients with malignant disease, intratumoral injection of DNA led to regression of tumor at distant sites [102] .